Seeing Is Believing
PHAT is currently covered by 5 analysts with an average price target of $19.4. This is a potential upside of $10.67 (122.22%) from yesterday's end of day stock price of $8.73.
Phathom Pharmaceuticals's activity chart (see below) currently has 18 price targets and 61 ratings on display. The stock rating distribution of PHAT is 93.62% BUY and 6.38% HOLD.
Analysts average stock forecasts to be materialized ratio is 23.21% with an average time for these price targets to be met of 39.63 days.
Highest price target for PHAT is $26, Lowest price target is $12, average price target is $19.4.
Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 13-Sep-2024.
Currently out of the existing stock ratings of PHAT, 44 are a BUY (93.62%), 3 are a HOLD (6.38%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$26
$17.22 (196.13%)
$26
2 months 7 days ago
(13-Sep-2024)
0/39 (0%)
$7.7 (42.08%)
Hold
$12
$3.22 (36.67%)
$10
3 months 11 days ago
(09-Aug-2024)
6/7 (85.71%)
$0.25 (2.13%)
29
Buy
$15
$6.22 (70.84%)
$22
1 years 8 months 19 days ago
(01-Mar-2023)
1/6 (16.67%)
$5.99 (66.48%)
152
Buy
$30
$21.22 (241.69%)
$35
1 years 8 months 19 days ago
(01-Mar-2023)
0/4 (0%)
$20.99 (232.96%)
Buy
$62
$52.74 (569.55%)
$50
3 years 1 months 3 days ago
(18-Oct-2021)
0/2 (0%)
$22.82 (77.64%)
What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?